Leeds Teaching Hospitals NHS Trust at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Leeds Teaching Hospitals NHS Trust brings 5 presentations to ASH 2026 in New Orleans. Its program centres on CLL and lymphoma treatment guided by measurable residual disease. Research covers ibrutinib with venetoclax and zanubrutinib, plus sessions on guidelines for paroxysmal nocturnal hemoglobinuria.
| Organization | ASH 2026 Attendance |
|---|---|
Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom | |
One of England's largest NHS hospital trusts, running St James's University Hospital and Leeds General Infirmary. | Symposium Fri Dec 11 7:00am–10:00am Consensus or Controversy? Documenting And Discussing Investigators’ Approaches to the Management of Patients with Chronic Lymphocytic Leukemia How clinical investigators differ on managing chronic lymphocytic leukemia, comparing their answers on hard cases alongside current data and ongoing research. Symposium Fri Dec 11 7:00am–10:00am From Controversies to Consensus in Paroxysmal Nocturnal Hemoglobinuria: Developing IPIG Guidelines Expert consensus on paroxysmal nocturnal hemoglobinuria, debating disease types, anticoagulation, and breakthrough hemolysis on complement inhibitors. Talk Fri Dec 11 5:00pm–5:55pm Oral Sat Dec 12 2:00pm–3:30pm Poster Sat Dec 12 5:30pm–7:30pm Oral Sun Dec 13 9:30am–11:00am |
Find decision makers at Leeds Teaching Hospitals NHS Trust
Tell us what you sell and we’ll find the people at Leeds Teaching Hospitals NHS Trust most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction